How well do you know about current therapies and ongoing developments for B-cell lymphomas? This is a chance to test your knowledge and learn more directly afterwards! (special: includes a pre- and post-article quiz activity) Néstor Zumaya writes. oncobites.blog/2025/12/10/p...

Ovarian cancer is the 8th most common malignancy among women and females worldwide. Because this cancer can provoke an immune response, future innovations in cancer treatment strategies are shifting towards emerging immunotherapies. Lubna Najm writes. oncobites.blog/2025/12/03/i...

The best screening test for colorectal cancer is the one that actually gets done. Capsule and robotic-assisted colonoscopy are making that easier, addressing barriers that have kept many people from getting screened. Maanya Rajasree Katta writes. oncobites.blog/2025/11/26/w...

Precision oncology is advancing faster than the healthcare infrastructure meant to deliver it. This gap is more representative of real consequences for patient survival, quality of life, and health equity. Shashank Gidipally, PharmD writes. oncobites.blog/2025/11/19/b...

OncoBites is back for the next writing cycle! Stay tuned weekly for the latest in cancer research in bite-sized pieces like this!

Taxanes are chemotherapy drugs that work by inhibiting the function of cytoskeletal microtubules in cancer cells. But what happens if a toxic dosage is given? Libby-Ann Harpaul-Sahadeo writes. oncobites.blog/2025/11/12/t...

In honor of #BreastCancerAwarenessMonth, here are our 5 latest articles on research related to breast cancer! 1) oncobites.blog/2025/05/28/t... 2) oncobites.blog/2023/05/03/a... 3) oncobites.blog/2022/09/21/a... 4) oncobites.blog/2022/03/23/b... 5) oncobites.blog/2022/02/02/y...

And that’s a wrap on our last cycle! OncoBites will be taking a short break from publishing to prepare for the new writing cycle. Thank you to all our contributors and readers so far, and we’ll be back with new content soon!

Preclinical oncology imaging is no longer a complementary tool, but an essential component of oncology drug development. Bethany Cooper writes. oncobites.blog/2025/09/24/t...

Researchers at UCLA proposed an interesting approach to CAR-T cell therapy: using focused ultrasound to only activate CAR-T cells within a tumor. Restricting CAR-T cell activity would theoretically limit its off-target & toxic effects. Anthony Tao writes. oncobites.blog/2025/09/17/u...

The dependence of cancer cells on various altered metabolic pathways can be exploited for therapeutic purposes. 1 new therapeutic approach is adipose manipulation transplantation, which can potentially suppress cancer cell proliferation. Colin Ong writes. oncobites.blog/2025/09/10/a...

A recent publication illustrates the power of data sharing from tissue and data collected in three clinical trials. Patty Spears writes. oncobites.blog/2025/09/03/p...

In a recent study, scientists have found a clear presence of immune cells, particularly T cells, in the cranial bones of patients with glioblastoma before surgery. Anna Salamero Boix writes. oncobites.blog/2025/08/27/s...

Vaccines have been recognized as promising chemotherapeutic instruments. Advances in how we look for & select antigens, as well as new platforms & delivery methods, pave the way for developing more specific & potent cancer vaccine options. Mariella Careaga writes. oncobites.blog/2025/08/20/a...

Taurine is one of the most important ingredients in energy drinks. In a novel study, researchers have found that taurine is not just an additive but rather a key player in the metabolic potential of cancer stem cells. Preeti Prangya Panda writes. oncobites.blog/2025/08/13/d...

We are once again opening our call for authors! Interested in joining us? Please fill out this form by August 22: docs.google.com/forms/d/e/1F... If you are unable to write with us this cycle but still wish to be on the list for future calls, please still fill out the form. Thank you!

Liquid biopsy is a non-invasive blood-based test that may help increase accessibility to screening & improve early detection of colorectal cancer in younger adults. It may also help to improve outcomes after a cancer diagnosis. Nicole Bowens, PhD writes. oncobites.blog/2025/08/06/c...

A recent study has found that a specific type of immune cell, Vd1-gd T cells, can help predict which patients are more likely to respond favorably to immunotherapy treatments. Joycelyn Ghansah, MA, MPH writes. oncobites.blog/2025/07/30/a...

How exactly is the gut microbiome linked to cancer? Oluoma Vivian Aneke writes. This article includes quotes from Dr. Adeel Khan, a haematologist/oncologist, epidemiologist and assistant professor at the University of Texas Southwestern Medical Center. oncobites.blog/2025/07/23/t...

While uncommon, a good number of individuals have developed #cancer while pregnant or shortly after giving birth. There’s no direct correlation between #pregnancy and the risk of cancer, so how could this happen? 🤔 @jessicadesamero.bsky.social writes. oncobites.blog/2025/07/16/c...

Cancer is a master in cellular manipulation and survival. In recent years, scientists have discovered that cancer cells can hijack healthy mitochondria from neighboring cells and abuse them for their own gain. Hema Saranya Ilamathi writes. oncobites.blog/2025/07/09/h...

KRAS mutations dominate the landscape of many solid tumors, but KRAS has been considered an undruggable target for decades. Since 2021, 6 novel KRAS targeting therapies have been developed & FDA-approved for certain cancer types. Chris Wang writes. oncobites.blog/2025/07/02/t...

Radiopharmaceuticals are drugs containing radioactive substances that can be used to both diagnose and treat cancer. 3 seminal trials have propelled radiopharmaceutical therapy into the mainstream. Bethany Cooper writes. oncobites.blog/2025/06/25/i...

Researchers found that a circuit between the nervous and immune system mediates cancer-associated depression and apathy. This highlights a unique neurobiological relationship between cancer, inflammation and psychiatric depression. Anthony Tao writes. oncobites.blog/2025/06/18/f...

Currently, most cancer treatment options rely on eradicating cancer cells. But what if you could turn cancer cells back into normal cells? Mikayla Sheild writes. oncobites.blog/2025/06/11/c...

Could the key to efficient #chemotherapy lie in our gut? Read along to find out. Yousra Iftequar writes. #gutmicrobiome oncobites.blog/2025/06/04/c...

Statistics show that about 10% of new breast cancer diagnoses in the U.S. represent women under 45 years old. For these young patients, their experience with #breastcancer presents unique physical and psychological challenges. Laura Urbina writes. oncobites.blog/2025/05/28/t...

"Neuropathic pain can affect a patient’s overall quality of life by influencing their daily interactions with family and friends, work, eating habits, and mental and emotional well-being." My piece for OncoBites on the benefits of using #gabapentin to relieve cancer-related #neuropathicpain

Gabapentin is commonly used to treat epilepsy and nerve pain caused by shingles. Did you know it can also be used to treat nerve pain related to cancer? Joycelyn Ghansah writes. oncobites.blog/2025/05/21/t...

Dark chocolate is a true celebration of indulgence. It may also have the potential to help treat cancer! Sandhyaa Venkatachalam writes. oncobites.blog/2025/05/14/a...

With CRISPR-based gene editing, scientists classified over 7000 BRCA2 gene variants as benign or pathogenic. This information can help better assess breast cancer risk in patients, especially those harboring unknown BRCA2 variants. Anthony Tao writes. #cancergenetics oncobites.blog/2025/05/07/t...

Radiomics is a powerful decoding tool that translates the hidden images in clinical scans and essentially turns any scan into a treasure map. This emerging field would help doctors predict and diagnose cancer early. Preeti Prangya Panda writes. oncobites.blog/2025/04/30/f...

Happy National #DNADay! 🧬 Here is my very 1st article with @oncobites.bsky.social from 2019 on alternative DNA structures and their anticancer implications! This marked the restart of my science writing journey, and I’ll always be grateful! 🥹 oncobites.blog/2019/08/14/d...

Happy National #DNADay! 🧬 Here are 4 of our past articles that talk about DNA structures in relation to cancer! 🔬 oncobites.blog/2021/02/17/t... oncobites.blog/2020/06/17/w... oncobites.blog/2020/01/08/l... oncobites.blog/2019/08/14/d...

Researchers have deciphered how tumor-associated macrophages communicate with brain tumor cells. This leads insight into what fuels #glioblastoma progression, opening new promising avenues for treating this deadly brain tumor. Mariella Careaga writes. #oncoimmunology oncobites.blog/2025/04/23/u...

One cancer treatment approach involves the use of bispecific antibodies (bsAbs)—engineered molecules that bind to 2 targets at the same time. Using bsAbs is a promising new #immunotherapy strategy for treating different malignancies. Dolores Mruk writes. oncobites.blog/2025/04/16/d...

This April, we're celebrating 7 years of OncoBites! Thank you so much for contributing and supporting us throughout the years, we appreciate it! ❤️ #cancerawareness #scicomm #cancerresearch

Cancer cells exhibit oncogenic signaling as a means of survival. But overactivation of this signaling can lead to cancer cell death. Can hyperactivating oncogenic signaling in cancer cells be a potential cancer treatment strategy? Colin Ong writes. #cancertherapy oncobites.blog/2025/04/09/c...

Considerable innovations in telehealth & remote monitoring have made outpatient CAR T-cell therapy possible. Continued innovations for treatment management can enhance accessibility & ensure more personalized & effective patient care. Nicole Bowens writes. oncobites.blog/2025/04/02/a...

My first piece for @oncobites.bsky.social is out! :)

Many fast-growing cancers have circadian rhythms that are desynchronized from healthy cells. But glioblastoma seems to keep a circadian rhythm that is in sync with healthy cells. Researchers recently uncovered why this is the case. @liuswrites.bsky.social writes. oncobites.blog/2025/03/26/t...

Obesity has been linked to cancer. But this link may not be as straightforward as you may think. In fact, one could say it is quite a paradox. Nicholas Egan writes. #obesity #cancer oncobites.blog/2025/03/19/t...

The FDA recently approved an immune targeting combination drug to treat solid tumors much faster! This new therapy can reduce strain on both the patient and the health care system. Brittane Strahan writes. #drugdevelopment #immunotherapy #cancer oncobites.blog/2025/03/05/n...

📣 New MicroBites! Microbes can help create ‘universal’ blood type O 🩸 Gut bacteria can help switch blood types A and B to the universal type O in the lab 🦠

The FDA recently approved Pfizer’s Braftovi combination regimen as a first-line treatment option for patients with BRAF-mutant metastatic colorectal cancer. Aishat Motolani writes. oncobites.blog/2025/02/26/m...

In just 15 years, scientists discovered a critical mutation and developed an FDA-approved drug for those living with brain tumors. Spencer Maingi writes. oncobites.blog/2025/02/19/v...

To start, here are 4 of our latest articles on potential cancer drugs, cancer disparities, & chemotherapy! - oncobites.blog/2025/01/01/b... - oncobites.blog/2025/01/15/p... - oncobites.blog/2025/01/22/d... - oncobites.blog/2025/02/05/h...

OncoBites is now on Bluesky! Please follow us for the latest in #cancerresearch simplified into bite-sized pieces!